Cervical cancer is an important health problem in women living in developing countries. Infection with some genotypes of human papillomavirus (HPV) is the most important risk factor associated with cervical cancer. Little information exists about HPV genotype distribution in rural and suburban regions of Mexico.
INTRODUCTION
Cervical cancer (CC) remains as one of the major health problems in developing countries. Estimated mortality for CC in Mexico in 2000 was 17.1/100,000 (1, 19) . Human papillomavirus (HPV) is the main causal factor of CC, but there are other risk factors that contribute to the development of CC such as smoking, multiple pregnancies, oral contraceptive use, family history of CC, high viral load and low socioeconomic status (2, 9) .
Overall prevalence of HPV infection among women with normal cytology worldwide is estimated to be 10.5% (6) ; Human papillomavirus infection from Tlaxcala however, HPV prevalence varied nearly 20 times among different populations, from 1.4% in Spain to 25.6% in Nigeria (5).
More than 40 HPV types infect the human anogenital tract (7) . HPV types are classified into low or high risk on the basis of their association with premalignant and malignant lesions (23) . In this regard, HPV type 16 is involved in ∼54% of all cases of invasive CC worldwide, whereas HPV type 18 causes about 11% of all cases (15) . Other HPV genotypes are less frequently associated with cancer. HPV types 16, 18, 31, 45, 53 and 58 have frequently been found in cervical samples of Mexican women (14, 16, 17, 22) . Little is known regarding HPV prevalence in women with and without CC in different Mexican populations. The obtained prevalence varied depending on the study. In cancer samples, HPV was detected in 87−92% of samples. High-grade squamous intraepithelial lesions (HGSIL) were detected in 29.4−88% of samples, and low-grade squamous intraepithelial lesions (LGSIL) were detected in 24−57% of samples and in normal smears in 12−17% of samples (3, 16, 22) . The general prevalence of HPV in women from the city of Durango (located in northern Mexico) was estimated at 4.8% (17) , but a higher prevalence (20.4%) was reported for HPV in the state of Morelos (14) .
Lazcano-Ponce et al. (14) found a prevalence of 16.7% in Mexican women <25 years of age, which decreased to 3.7% in women 25−44 years of age and increased to 23% in women >65 years of age. Little information exists about HPV in rural and suburban regions of the country, and little is known about the molecular epidemiology of HPV in the state of Tlaxcala, Mexico. In the present study we determined the prevalence of HPV genotypes 6, 11, 16, 18 and 31 in women treated at a General Hospital in Tlaxcala, which is also situated in the central region of Mexico and is one of the poorest states in Mexico.
MATERIALS AND METHODS

Study population
We studied women requesting cervical Papanicolaou A total of 236 samples were analyzed. Patient data such as age, residence, age at first sexual intercourse, number of sexual partners and number of pregnancies were also collected from a questionnaire. The study was approved by the institutional ethics committee. The purpose and procedures of the study were explained to patients, and informed consent was obtained from all participants.
Collection of specimens
Two cervical samples were obtained from each patient using a cytobrush. The first sample was used for cytological diagnosis. Papanicolaou smears were evaluated by a pathologist according to the Bethesda diagnostic criteria (18) .
The second sample was used to detect HPV by PCR. In addition to Pap smear, each woman had colposcopy and, when necessary, a biopsy was obtained for pathological diagnosis.
No biopsy was obtained for research purposes.
DNA extraction
Cervical smears were placed in tubes containing 5 ml phosphate-buffered saline (PBS), vigorously shaken, and centrifuged for 10 min at 4000 × g. Pellets were resuspended in 1 ml PBS, and a 0.5-ml aliquot was used for DNA extraction using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany).
Purified DNA was suspended in 100 µl of water and stored at −20 o C until use. All samples were tested for integrity of DNA by 1% agarose gel electrophoresis.
PCR assays
Detection of HPV genotypes 6, 11, 16, 18, and 31 was carried out using primer-specific PCR (21) . Amplification (24). Gels were stained with ethidium bromide (1 g/ml), observed with an ultraviolet transilluminator, and photographed using a digital camera (DC290, Kodak, Rochester, NY).
Statistical analysis
Frequencies of clinical data were calculated. Differences between groups were calculated by 2 test; p <0.05 was considered significant. Data were analyzed using SPSS for Windows, v.12 (Chicago, IL).
RESULTS
Study population
A total of 236 cervical specimens were analyzed for cytological diagnosis and HPV detection.
LGSIL was diagnosed in 97 (41.1%) cases, HGSIL in 39 (16.5%) cases and normal cervical smears in 100 cases (42.4%). LGSIL, low-grade squamous intraepithelial lesion; HGSIL, high-grade squamous intraepithelial lesion. 
Prevalence of HPV types
Cervical lesions and clinical variables
Mean age of first intercourse of all the women enrolled in the study was 19.3 years (range: 12−32 years). Mean age of first intercourse in the HGSIL group (18.5 years) was similar to that of the normal group (19.4 years). We did not find statistical differences between age of first intercourse and grade of cervical neoplasia.
Women in the study had a mean of 2.7 pregnancies. We did not find an association between positive history of multiple pregnancies and grade of neoplasia (Table 4 ). We found an overall HPV prevalence of 31.3% in women treated at the General Hospital, Tlaxcala, with 22% in women with normal cervical cytology. This represents a higher prevalence of HPV infection with regard to other similar studies (16, 17) . In a similar study conducted with women living in a rural zone in Puebla, which is located ~100 km from Tlaxcala, we found a lower general HPV prevalence (20%) with 14.7% in women with normal cytology (22) . We expected to obtain comparable prevalence values in these studies because both involved women residing in rural zones and women who were treated at a general hospital. However, the higher HPV prevalence in Tlaxcala may reflect a limited infrastructure for health services, combined with a higher human population density; Tlaxcala municipality has 1597 Human papillomavirus infection from Tlaxcala p/km 2 vs. Atlixco municipality, which has 532 p/km 2 (10, 11). It is noteworthy that women with normal cytology had a higher rate of HPV 18 infection than in other states in Mexico (15, 17) . These results must be interpreted with caution because we analyzed a biased population. In fact, the women in our study were treated at a dysplasia clinic; therefore, the prevalence of squamous intraepithelial lesions and HPV is higher than in an open population. Concurrent infection with more than one HPV genotype was found in 10.8% of the analyzed population. This value is in the range observed for multiple infections among different studies (4, 8, 12, 20, 22) .
Sexual behavior in men in
Simultaneous infections have been frequently observed among younger women (4). However, in this and in our previous study (22) , the mean age of women with multiple infections was ~45 years (range: 26−63 years).
Age-specific HPV prevalence has been estimated in different studies worldwide. HPV infection characteristically peaks soon after initiation of sexual activity, usually among women in their early twenties. After the age of 25 years, HPV prevalence is higher in less-developed countries than in developed countries, but both showed a continuous decline with increasing age until 45−54 years of age when estimates increased in both regions (6, 12) . We found a peak in the 18-to 24-year-old group and a decrease in prevalence until the 55-to 64-year-old group where we found a small second peak of prevalence.
Lazcano-Ponce et al. (14) evaluated the correlation between patients' age and HPV prevalence in Mexican women. (14, 22) . Mexican women seem to have the same age prevalence curve, regardless of the studied region. The second peak of prevalence has been observed worldwide, with the exception of Asia where rates continue to decrease (6) . It is important to determine if the age-specific HPV prevalence is dependent on HPV type in order to begin to understand the factors involved in this distribution pattern. It has been reported that women with at least seven full-term and from the Mexican Institute of Social Security.
